Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Announcement Summary
For personal use only
Entity name
SINGULAR HEALTH GROUP LTD
Date of this announcement
Friday January 21, 2022
The +securities the subject of this notification are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are not quoted, and are not intended to be quoted, on ASX
Total number of +securities to be issued/transferred
Total number of | |||
ASX +security | +securities to be | ||
code | Security description | issued/transferred | Issue date |
SHGAU | OPTION EXPIRING 07-JAN-2024 EX $0.50 | 300,000 | 10/01/2022 |
SHGAV | OPTION EXPIRING 07-JAN-2024 EX $0.60 | 400,000 | 10/01/2022 |
SHGAT | OPTION EXPIRING 07-JAN-2024 EX $0.40 | 300,000 | 10/01/2022 |
Refer to next page for full details of the announcement
Notification of Issue, Conversion or Payment up of Unquoted | 1 / 6 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
SINGULAR HEALTH GROUP LTD
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2 | Registered number type | Registration number |
ABN | 58639242765 | |
1.3 | ASX issuer code | |
SHG |
- The announcement is New announcement
- Date of this announcement
21/1/2022
Notification of Issue, Conversion or Payment up of Unquoted | 2 / 6 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 2 - Issue details
For personal use only
2.1 The +securities the subject of this notification are:
+Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B that are not quoted, and are not intended to be quoted, on ASX
Previous Appendix 3B details: | ||
Announcement Date and | Announcement Title | Selected Appendix 3B to submit quotation |
Time | request | |
31-Dec-2021 15:03 | New - Proposed issue of securities - | |
A placement or other type of issue | ||
SHG | ||
2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B?
No
Notification of Issue, Conversion or Payment up of Unquoted | 3 / 6 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 3A - number and type of +securities the subject of this notification (existing class or new class) where issue has previously been notified to ASX in an Appendix 3B
only | |||
Placement Details | |||
ASX +security code and description | |||
SHGAU : OPTION EXPIRING 07-JAN-2024 EX $0.50 | |||
use | Date the +securities the subject of this notification were issued | ||
10/1/2022 | |||
Any other information the entity wishes to provide about the +securities the subject of this notification | |||
Issue details
For personal
Number of +securities
300,000
Were the +securities issued for a cash consideration?
No
Please describe the consideration being provided for the +securities
Issued in respect of Engagement letter for the provision of research and promotional activities and associated activities.
ASX +security code and description
SHGAV : OPTION EXPIRING 07-JAN-2024 EX $0.60
Date the +securities the subject of this notification were issued
10/1/2022
Any other information the entity wishes to provide about the +securities the subject of this notification
Notification of Issue, Conversion or Payment up of Unquoted | 4 / 6 |
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Issue details
Number of +securities | ||||
only | 400,000 | |||
Were the +securities issued for a cash consideration? | ||||
No | ||||
Please describe the consideration being provided for the +securities | ||||
Issued in respect of Engagement letter for the provision of research and promotional activities and associated activities. | ||||
use | ASX +security code and description | |||
SHGAT : OPTION EXPIRING 07-JAN-2024 EX $0.40 | ||||
Date the +securities the subject of this notification were issued | ||||
10/1/2022 | ||||
personalFor | Any other information the entity wishes to provide about the +securities the subject of this notification | |||
Issue details
Number of +securities 300,000
Were the +securities issued for a cash consideration?
No
Please describe the consideration being provided for the +securities
Issued in respect of Engagement letter for the provision of research and promotional activities and associated activities.
Notification of Issue, Conversion or Payment up of Unquoted | 5 / 6 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Singular Health Group Ltd. published this content on 21 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 January 2022 05:51:02 UTC.